These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21716315)

  • 1. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.
    Vandenbroeck K; Alvarez J; Swaminathan B; Alloza I; Matesanz F; Urcelay E; Comabella M; Alcina A; Fedetz M; Ortiz MA; Izquierdo G; Fernandez O; Rodriguez-Ezpeleta N; Matute C; Caillier S; Arroyo R; Montalban X; Oksenberg JR; Antigüedad A; Aransay A
    Genes Immun; 2012 Jan; 13(1):21-8. PubMed ID: 21716315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
    Leikfoss IS; Keshari PK; Gustavsen MW; Bjølgerud A; Brorson IS; Celius EG; Spurkland A; Bos SD; Harbo HF; Berge T
    PLoS One; 2015; 10(7):e0132957. PubMed ID: 26203907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of suppressor of cytokine signaling 1 (SOCS1) gene dramatically increases in relapsing-remitting multiple sclerosis.
    Pahlevan Kakhki M; Rakhshi N; Heidary M; Behmanesh M; Nikravesh A
    J Neurol Sci; 2015 Mar; 350(1-2):40-5. PubMed ID: 25701091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.
    Leikfoss IS; Mero IL; Dahle MK; Lie BA; Harbo HF; Spurkland A; Berge T
    Genes Immun; 2013 Jan; 14(1):62-6. PubMed ID: 23151489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.
    Hirschfield GM; Xie G; Lu E; Sun Y; Juran BD; Chellappa V; Coltescu C; Mason AL; Milkiewicz P; Myers RP; Odin JA; Luketic VA; Bacon B; Bodenheimer H; Liakina V; Vincent C; Levy C; Pillai S; Lazaridis KN; Amos CI; Siminovitch KA
    Genes Immun; 2012 Jun; 13(4):328-35. PubMed ID: 22257840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
    Lopez de Lapuente A; Pinto-Medel MJ; Astobiza I; Alloza I; Comabella M; Malhotra S; Montalban X; Zettl UK; Rodríguez-Antigüedad A; Fernández O; Vandenbroeck K
    Mult Scler; 2015 Oct; 21(12):1498-512. PubMed ID: 25623250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex.
    Zuvich RL; Bush WS; McCauley JL; Beecham AH; De Jager PL; ; Ivinson AJ; Compston A; Hafler DA; Hauser SL; Sawcer SJ; Pericak-Vance MA; Barcellos LF; Mortlock DP; Haines JL
    Hum Mol Genet; 2011 Sep; 20(17):3517-24. PubMed ID: 21653641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
    J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients.
    Amirzargar A; Khosravi F; Dianat S; Hushmand F; Maryousef P; Foroushani AR; Lotfi J; Nikbin B
    Mult Scler; 2007 Mar; 13(2):253-5. PubMed ID: 17439892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the suppressor of cytokine signaling 1 (SOCS1) gene polymorphisms with acute coronary syndrome in Mexican patients.
    Vargas-Alarcon G; Posadas-Sanchez R; Posadas-Romero C; Gonzalez-Salazar C; Cardoso-Saldaña G; Martinez-Rios MA; Peña-Duque MA; Obil-Chavarria C; Perez-Mendez O; Fragoso JM
    Mol Immunol; 2014 Nov; 62(1):137-41. PubMed ID: 24997329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma.
    Harada M; Nakashima K; Hirota T; Shimizu M; Doi S; Fujita K; Shirakawa T; Enomoto T; Yoshikawa M; Moriyama H; Matsumoto K; Saito H; Suzuki Y; Nakamura Y; Tamari M
    Am J Respir Cell Mol Biol; 2007 Apr; 36(4):491-6. PubMed ID: 17099141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians.
    Bashinskaya VV; Kulakova OG; Kiselev IS; Baulina NM; Favorov AV; Boyko AN; Tsareva EY; Favorova OO
    J Neuroimmunol; 2015 May; 282():85-91. PubMed ID: 25903733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
    Sedeño-Monge V; Arcega-Revilla R; Rojas-Morales E; Santos-López G; Perez-García JC; Sosa-Jurado F; Vallejo-Ruiz V; Solis-Morales CL; Aguilar-Rosas S; Reyes-Leyva J
    J Neuroimmunol; 2014 Aug; 273(1-2):117-9. PubMed ID: 24951315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS gene family expression profile in the blood of multiple sclerosis patients.
    Toghi M; Taheri M; Arsang-Jang S; Ohadi M; Mirfakhraie R; Mazdeh M; Sayad A
    J Neurol Sci; 2017 Apr; 375():481-485. PubMed ID: 28196747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations.
    Suppiah V; Goris A; Alloza I; Heggarty S; Dubois B; Carton H; Antigüedad A; Mendibe M; McDonnell G; Droogan A; Hawkins S; Graham C; Vandenbroeck K
    Int J Immunogenet; 2005 Dec; 32(6):383-8. PubMed ID: 16313303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk alleles for multiple sclerosis in multiplex families.
    D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
    Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis.
    Goertsches R; Comabella M; Navarro A; Perkal H; Montalban X
    J Neuroimmunol; 2005 Jul; 164(1-2):140-7. PubMed ID: 15913795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
    Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
    Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EVI5 is a risk gene for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
    Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations of SOCS1 are associated with chronic hepatitis B virus infection.
    Zhang P; Li F; Li N; Zhu Q; Yang C; Han Q; Chen J; Lv Y; Yu L; Wei P; Liu Z
    Hum Immunol; 2014 Aug; 75(8):709-14. PubMed ID: 24768946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.